TABLE 2.

R-pyocin production and susceptibility of 47 clinical isolates

IsolateR-pyocin typeSNP genotypeSerotypeaLysis byb:
R1-pyocinR2-pyocinR5-pyocin
03101A42AO1+++
051016C22O1+++
131040C1AO1+++
13112C40AO1+++
15109F429O1+++
27101EC4AO1+++
131206592O3+++
15104F62AO3+++
241012C25O3+++
06101279AO6+++
06103CC2AO6+++
131130F9EO6++
27102841ENT++
131091F429O1++
0110111BAEO6++
061041AF9AO6+
1010712C2AO6++
1310614F8AO6++
1310811BAEO6++
13111185AAO6+
131281062AO6±
1510110C2EO6++
1610110C2EO6++
1910517C2EO6++
2610314F92O6+
PAK155AAO6++
PAO120002O5
2710320812O5
PA142D421O10
061052D421O10
101032D421O10
131242D421O10±
301012D421O10
131222F661O10±
131192239AO12
13118-S12239AO15+
0810252C1AO4++
1010252F92O4++
2110654F82O4
0310350F92O11±
151025E429O11
191015F469O11
081015F469O11
131175F469O11
221015F469O11
261015F469O11
1910256D92O12
2110256D92O12
151085E429O15+±
281015261ANT
  • a LPS O-serotype lysis was determined with supernatants from strains PAK (R1-pyocin), PA14 (R2-pyocin), and 15108-1 (R5-pyocin), and the results were compared to those for the corresponding R-pyocin deletion mutant. NT, not typeable.

  • b +, lysis; −, no lysis; ±, weak or fuzzy lysis zone.